Advanced search
Publication Cover
OncoImmunology Volume 8, 2019 - Issue 2
Submit an article Journal homepage
1,803
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy

Yun ZhouState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China;Department of Gynecology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. ChinaView further author information
,
Chang-long ChenState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China;Department of Radiation Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, P. R. ChinaView further author information
,
Sen-wei JiangState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China;Department of Gynecology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. ChinaView further author information
,
Yanling FengState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China;Department of Gynecology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. ChinaView further author information
,
Linjing YuanDepartment of Gynecology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P. R. ChinaView further author information
,
Ping ChenState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China;Department of VIP region, Sun Yat-sen University Cancer Center, Guangzhou, P. R. ChinaView further author information
,
Lan ZhangDepartment of Radiotherapy, Yunnan Cancer Hospital & The Third Affiliated Hospital of Kunming Medical University, Kunming, P. R. ChinaView further author information
,
Shuting HuangState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China;Department of Gynecology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. ChinaView further author information
,
Jundong LiState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China;Department of Gynecology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. ChinaView further author information
,
Jian-Chuan XiaState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China;Department of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, P. R. ChinaView further author information
&
Min ZhengState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China;Department of Gynecology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. ChinaCorrespondence[email protected] [email protected] [email protected]
View further author information
 show all
Article: e1528411 | Received 11 May 2018, Accepted 20 Sep 2018, Published online: 11 Nov 2018

Related Research Data

Phenotypic characterization and anticancer capacity of CD8+ cytokine-induced killer cells after antigen-induced expansion
Source: Public Library of Science (PLoS)
The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients.
Source: Springer Science and Business Media LLC
A distinct innate lymphoid cell population regulates tumor-associated T cells
Source: Springer Science and Business Media LLC
Ovarian Cancer
Source: Annual Reviews
Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase–Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer
Source: American Association for Cancer Research (AACR)
Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study
Source: Springer Science and Business Media LLC
Patterns of Recurrence and Clinical Outcome of Patients With Stage IIIC to Stage IV Epithelial Ovarian Cancer in Complete Response After Primary Debulking Surgery Plus Chemotherapy or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery: An Italian Multicenter Retrospective Study
Source: BMJ
Maintenance therapy with autologous cytokine-induced killer cells in patients with advanced epithelial ovarian cancer after first-line treatment.
Source: Ovid Technologies (Wolters Kluwer Health)
Cancer Statistics, 2015
Source: Wiley
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
Source: Proceedings of the National Academy of Sciences
Autologous cytokine-induced killer cell immunotherapy may improve overall survival in advanced malignant melanoma patients.
Source: Future Medicine Ltd
Targeted Therapies in the Management of Ovarian Cancer: A Focus on Older Patients
Source: Springer Science and Business Media LLC
Interleukin-15-activated cytokine-induced killer cells may sustain remission in leukemia patients after allogeneic stem cell transplantation: feasibility, safety and first insights on efficacy.
Source: Ferrata Storti Foundation (Haematologica)
Characterization of the recognition and functional heterogeneity exhibited by cytokine‐induced killer cell subsets against acute myeloid leukaemia target cell
Source: Wiley
Immunotherapy in ovarian cancer.
Source: Elsevier BV
Aging and immunity – Impact of behavioral intervention
Source: Elsevier BV
Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer
Source: Informa UK Limited
Tumor-infiltrating NY-ESO-1–specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
Source: Proceedings of the National Academy of Sciences
Coronin-1C is a novel biomarker for hepatocellular carcinoma invasive progression identified by proteomics analysis and clinical validation
Source: Springer Science and Business Media LLC
Dendritic cell-activated cytokine-induced killer cell-mediated immunotherapy is safe and effective for cancer patients >65 years old.
Source: Spandidos Publications
Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma
Source: Elsevier BV

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.